Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venturepharm Laboratories, now operating as China Health Group Inc., is a prominent Chinese contract research and manufacturing organization (CRMO) that provides integrated "one-stop" services for drug discovery and development. Founded in 2001, the company offers a comprehensive suite of services including medicinal chemistry, preclinical research, clinical trial management, and GMP-compliant manufacturing of APIs and finished dosages. Venturepharm focuses on a wide range of therapeutic areas such as oncology, CNS, and infectious diseases, leveraging its "Full Service Plus" model to support both domestic and international pharmaceutical clients. The company is listed on the Hong Kong Stock Exchange and maintains significant R&D and production facilities across China, including a major base in Hainan. Its business model uniquely integrates CRO, CMO, and CSO functions with venture capital and royalty-sharing arrangements to accelerate drug commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venturepharm Laboratories.